DURHAM – Codetta Bio, a developer of biomarker measurement tools, has named a new chief executive officer.
Jacques Corriveau will lead Codetta’s next phase of commercial growth as the team advances the development of its disruptive multi-omic solution and brings its technology to market, the company says.
“Corriveau joins Codetta with more than 25 years of commercial and operational leadership in life science tools, biopharma, and diagnostics, and has demonstrated success in developing and growing early-stage companies,” Codetta says.
“Most recently, Corriveau served as President and CEO at Ultivue, Inc. for three years, where he led organizational growth in commercial operations and manufacturing capacity. Prior to that, he worked for AstraZeneca’s Definiens Inc. as Vice President and General Manager for North America. Corriveau also spent 10 years in various commercial roles at NanoString Technologies, where he created, developed, and executed go-to-market strategies.”
Former CEO Dr. Anthony Lemmo is now chief technology officer.
To learn more about Codetta Bio, see http://www.codettabio.com.
